AAAAAA
Results: 26-50/98
Authors:
MESSERLI FH
MICHALEWICZ L
Citation: Fh. Messerli et L. Michalewicz, CARDIAC EFFECTS OF COMBINATION THERAPY, American journal of hypertension, 10(7), 1997, pp. 146-152
Authors:
MESSERLI FH
Citation: Fh. Messerli, COMPLEMENTARY ACTIONS AND RISK REDUCTION - THE RATIONALE FOR COMBINATION OF AN ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR WITH A NONDIHYDROPYRIDINE CALCIUM-ANTAGONIST, Journal of hypertension, 15, 1997, pp. 35-38
Authors:
MESSERLI FH
Citation: Fh. Messerli, CALCIUM-ANTAGONIST CONTROVERSY REASSESSED - DIFFICILE EST SATIRAM NONSCRIBERE, European heart journal, 18(1), 1997, pp. 166-167
Authors:
LUCINI D
MILANI RV
VENTURA HO
MESSERLI FH
MURGO JP
MALLIANI A
PAGANI M
Citation: D. Lucini et al., STUDY OF THE VASCULAR AND AUTONOMIC EFFECTS OF CYCLOSPORINE TREATMENTIN HUMANS, Hypertension, 30(4), 1997, pp. 51-51
Authors:
MESSERLI FH
GROSSMAN E
GRODZICKI T
KOWEY P
Citation: Fh. Messerli et al., NIFEDIPINE FOR HYPERTENSIVE EMERGENCIES - REPLY, JAMA, the journal of the American Medical Association, 277(10), 1997, pp. 790-790
Authors:
MESSERLI FH
Citation: Fh. Messerli, HYPERTENSION IN SPECIAL POPULATIONS, The Medical clinics of North America, 81(6), 1997, pp. 1335
Authors:
MESSERLI FH
GROSSMAN E
Citation: Fh. Messerli et E. Grossman, SHOULD BETA-BLOCKERS BE BANNED FROM THE ANTIHYPERTENSIVE ARSENAL IN THE ELDERLY, Circulation, 96(8), 1997, pp. 3341-3341
Authors:
MESSERLI FH
Citation: Fh. Messerli, NIFEDIPINE TRIALS, Circulation, 95(6), 1997, pp. 1671-1671
Authors:
MESSERLI FH
Citation: Fh. Messerli, LORSARTAN IMPROVES INSULIN SENSITIVITY - IN REPLY, Archives of internal medicine, 157(9), 1997, pp. 1041-1041
Authors:
BLACK HR
COHEN JD
KAPLAN NM
FERDINAND KC
CHOBANIAN AV
DUSTAN HP
GIFFORD RW
MOSER M
SHEPS SG
AGODOA L
AUGUST PA
BAKRIS GL
BURT V
BUSSE W
CARTER BL
CHESLEY FD
CLEEMAN J
COHN JN
CREGLER LL
CRESPO C
CUSHMAN WC
CUTLER J
DARROW MD
DEQUATTRO VL
DEVEREUX RB
DWORKIN LD
ELLIOTT WJ
EPSTEIN M
FALKNER B
FERRARIO CM
FLACK JM
FRISHMAN W
FROHLICH ED
GREEN LA
GRIMM RH
HAGBERG JM
HALL WD
HANDLER J
HAVAS S
HILL MN
HORAN MJ
HSUEH WA
HYMAN BN
IZZO JL
JAMERSON K
KILEY JP
KOCHAR MS
KOLASA KM
KRAKOFF LR
LEVY D
LINDHEIMER MD
LUEPKER RV
MALONE MEL
MASSIE B
MATERSON BJ
MERCHANT J
MESSERLI FH
MILLER NH
MOORE MA
MUSTONEALEXANDER L
OPARIL S
PERRY HM
PICKERING TG
PRATT JH
RAM CVS
RANDALL OS
REED JW
ROBERTS RW
ROCCELLA EJ
ROGUS SD
SAUNDERS E
SCHRON E
SCHWARTZ G
SIBAI BM
SNYDER D
SOWERS JR
STAMLER J
TEMPLE R
TEXTOR S
THOM T
VIDT DG
WEBER M
WEINBERGER MH
WEINSHILBOUM R
WHELTON PK
WHISNANT JP
WIEBERS DO
WINSTON MC
WRIGHT JT
LENFANT C
CASSER L
COLMAN PJ
EDWARDS T
FEELEY DM
GAJEWSKI J
LEVINE D
MANGER W
MARSHALL EC
NICKEY WA
ROBERT RW
SECREST BG
SINGER EH
WHISNANT JP
WILSON GJ
YOUNG JM
BACHMAN JW
CAMPESE VM
CARR AA
HAND M
HOLDEN DC
JAMIESON MJ
JULIUS S
MENSAH GA
PRISANT M
SULLIVAN JM
WILSON DJ
MOROSCO G
ANDERSON DE
WAUGH D
Citation: Hr. Black et al., THE 6TH REPORT OF THE ,-EVALUATION,-AND-TREATMENT-OF-HIGH-BLOOD-PRESSURE, Archives of internal medicine, 157(21), 1997, pp. 2413-2446
Authors:
MESSERLI FH
SCHMIEDER RE
WEIR MR
Citation: Fh. Messerli et al., SALT - A PERPETRATOR OF HYPERTENSIVE TARGET ORGAN DISEASE, Archives of internal medicine, 157(21), 1997, pp. 2449-2452
Authors:
GROSSMAN E
MESSERLI FH
Citation: E. Grossman et Fh. Messerli, CALCIUM-ANTAGONISTS IN CARDIOVASCULAR-DISEASE - A NECESSARY CONTROVERSY BUT AN UNNECESSARY PANIC, The American journal of medicine, 102(2), 1997, pp. 147-149
Authors:
GROSSMAN E
MESSERLI FH
Citation: E. Grossman et Fh. Messerli, EFFECT OF CALCIUM-ANTAGONISTS ON PLASMA NOREPINEPHRINE LEVELS, HEART-RATE, AND BLOOD-PRESSURE, The American journal of cardiology, 80(11), 1997, pp. 1453-1458
Authors:
MESSERLI FH
Citation: Fh. Messerli, CARDIOPROTECTION - NOT ALL CALCIUM-ANTAGONISTS ARE CREATED EQUAL - 2ND ROUND, The American journal of cardiology, 79(6), 1997, pp. 788
Authors:
AEPFELBACHER FC
MESSERLI FH
NUNEZ E
MICHALEWICZ L
Citation: Fc. Aepfelbacher et al., CARDIOVASCULAR EFFECTS OF A TRANDOLAPRIL VERAPAMIL COMBINATION IN PATIENTS WITH MILD-TO-MODERATE ESSENTIAL-HYPERTENSION/, The American journal of cardiology, 79(6), 1997, pp. 826
Authors:
SCHMIEDER RE
ROCKSTROH JK
LUCHTERS G
HAMMERSTEIN U
MESSERLI FH
Citation: Re. Schmieder et al., COMPARISON OF EARLY TARGET ORGAN DAMAGE BETWEEN BLACKS AND WHITES WITH MILD SYSTEMIC ARTERIAL-HYPERTENSION, The American journal of cardiology, 79(12), 1997, pp. 1695
Authors:
MICHALEWICZ L
MESSERLI FH
Citation: L. Michalewicz et Fh. Messerli, CARDIAC EFFECTS OF CALCIUM-ANTAGONISTS IN SYSTEMIC HYPERTENSION, The American journal of cardiology, 79, 1997, pp. 39-46
Authors:
SOWERS JR
FRISHMAN WH
ZANCHETTI A
OPIE LH
HOBBS FDR
EPSTEIN M
MESSERLI FH
Citation: Jr. Sowers et al., CARDIAC EFFECTS OF CALCIUM-ANTAGONISTS IN SYSTEMIC HYPERTENSION - DISCUSSION, The American journal of cardiology, 79, 1997, pp. 47-48
Authors:
MESSERLI FH
MICHALEWICZ L
Citation: Fh. Messerli et L. Michalewicz, SAFETY OF HEART RATE-LOWERING CALCIUM-ANTAGONISTS - LESSONS FROM CONTROLLED TRIALS, The American heart journal, 134(2), 1997, pp. 21-24
Authors:
MESSERLI FH
Citation: Fh. Messerli, WHAT, IF ANYTHING, IS CONTROVERSIAL ABOUT CALCIUM-ANTAGONISTS, American journal of hypertension, 9(12), 1996, pp. 177-181
Authors:
MESSERLI FH
GRODZICKI T
Citation: Fh. Messerli et T. Grodzicki, HYPERTENSION AND CORONARY-ARTERY DISEASE IN THE ELDERLY, Clinics in geriatric medicine, 12(1), 1996, pp. 41
Authors:
LAVIE CJ
MILANI RV
MESSERLI FH
Citation: Cj. Lavie et al., PREVENTION AND REDUCTION OF LEFT-VENTRICULAR HYPERTROPHY IN THE ELDERLY, Clinics in geriatric medicine, 12(1), 1996, pp. 57
Authors:
MESSERLI FH
Citation: Fh. Messerli, CENTRAL BLOOD-VOLUME - AN EXPLANATION OF RACIAL-DIFFERENCES IN LEFT-VENTRICULAR MASS - REPLY, Journal of the American College of Cardiology, 28(2), 1996, pp. 539-539
Authors:
MESSERLI FH
Citation: Fh. Messerli, WHATEVER HAPPENED TO THE CALCIUM-ANTAGONIST CONTROVERSY, Journal of the American College of Cardiology, 28(1), 1996, pp. 12-13
Authors:
KETELHUT RG
KETELHUT K
MESSERLI FH
BADTKE G
Citation: Rg. Ketelhut et al., FITNESS IN THE FIT - DOES PHYSICAL CONDITIONING AFFECT CARDIOVASCULARRISK-FACTORS IN MIDDLE-AGED MARATHON RUNNERS, European heart journal, 17(2), 1996, pp. 199-203